Guam vs Malta: The number of people with susceptibility test result for rifampicin
Guam
35
in 2021
Malta
27
in 2021
Guam rank
126th
Malta rank
129th
The number of people with susceptibility test result for rifampicin over time
- Guam
- Malta
How they compare
Guam currently reports 35 against 27 in Malta, a difference of 8.
That makes Guam's figure about 1.3 times Malta's.
Across all 5 years both countries report, Guam has been ahead every year.
Guam ranks 126th and Malta ranks 129th of 155 countries.
Guam has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guam | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 50.33 | 29 | 21.33 | Guam |
| 2020s | 36.5 | 30.5 | 6 | Guam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Guam or Malta?
- Guam, at 35 against 27 in Malta as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Guam and Malta?
- 8, with Guam ahead.
- How many years of comparable data are there for Guam and Malta?
- 5 years are reported by both, from 2017 to 2021.
- How do Guam and Malta rank globally for the number of people with susceptibility test result for rifampicin?
- Guam ranks 126th and Malta ranks 129th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.